Extracellular matrix metalloproteinase inducer and matrix metalloproteinase-2 overexpression is associated with loss of hormone receptor expression and poor prognosis in endometrial cancer. [electronic resource]
- Oncology letters Jul 2015
- 342-348 p. digital